Manufacture of pharmaceutical preparations
HP HALDEN PHARMA AS
Revenue 2024
NOK 1.3bn
Operating profit
NOK 76.3m
Equity
NOK 57.8m
Incorporated
2023
Employees
694
Share capital
NOK 7.8m
Key figures · 2024
Current ratio
1.97
Equity ratio
7.1%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 6.0% | |
| Net margin (%%) | 3.8% | |
| Return on assets (%%) | 9.4% | |
| Likviditet | ||
| Current ratio | 1.97 | |
| Working capital | 373.0m | |
| Soliditet | ||
| Equity ratio (%%) | 7.1% | |
| Debt-to-equity ratio | 13.10 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.